OTC Healthcare - United Kingdom
OTC Healthcare in the United Kingdom : Market Insight
EXECUTIVE SUMMARY
KEY TRENDS AND DEVELOPMENTS
Convenience Shoppers Children Ageing Population Self care and self medication MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
Table 2 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification Vitamins & Dietary Supplements Registration and Classification Generics Consumer Expenditure on Health Goods and Medical Services
Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
Local Company Profiles - United Kingdom
Bayer Plc - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 2 Bayer Plc: Key Facts
Summary 3 Bayer Plc: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 4 Bayer Plc: Competitive Position 2006
Ernest Jackson Ltd - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 5 Ernest Jackson Ltd: Key Facts
COMPANY BACKGROUND PRODUCTION
Summary 6 Ernest Jackson Ltd: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 7 Ernest Jackson Ltd: Competitive Position 2006
GlaxoSmithKline Plc - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 8 GlaxoSmithKline Plc: Key Facts
Summary 9 GlaxoSmithKline Plc: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 10 GlaxoSmithKline: Competitive Position 2006
Johnson & Johnson MSD - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 11 Johnson & Johnson MSD: Key Facts
Summary 12 Johnson & Johnson MSD: Operational Indicators
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 13 Johnson & Johnson MSD: Competitive Position 2006
Novartis Consumer Health UK Ltd - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 14 Novartis Consumer Health UK Ltd: Key Facts
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 15 Novartis Consumer Health UK Ltd: Competitive Position 2006
Procter & Gamble Ltd - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 16 Procter & Gamble UK: Key Facts
COMPANY BACKGROUND COMPETITIVE POSITIONING
Summary 17 Procter & Gamble UK: Competitive Position 2006
Reckitt Benckiser Plc - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 18 Reckitt Benckiser UK Ltd: Key Facts
Summary 19 Reckitt Benckiser UK Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 20 Reckitt Benckiser Plc: Competitive Position 2006
Seven Seas Ltd - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 21 Seven Seas Ltd: Key Facts
Summary 22 Seven Seas Ltd: Operational Indicators
COMPANY BACKGROUND PRODUCTION COMPETITIVE POSITIONING
Summary 23 Seven Seas Ltd: Competitive Position 2006
SSL International Plc - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 24 SSL International Plc: Key Facts
Summary 25 SSL International Plc: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 26 SSL International Plc: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 27 SSL International Plc: Competitive Position 2006
Wyeth Consumer Healthcare Ltd - OTC Healthcare - United Kingdom
STRATEGIC DIRECTION KEY FACTS
Summary 28 Wyeth Consumer Healthcare: Key Facts
Summary 29 Wyeth Consumer Healthcare: Operational Indicators
COMPANY BACKGROUND PRODUCTION
Summary 30 Wyeth Consumer Healthcare: Production Statistics 2006
COMPETITIVE POSITIONING
Table 13 Summary4 Wyeth Consumer Healthcare: Competitive Position 2006
Cough, cold and allergy (hay fever) remedies in the United Kingdom
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 14 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 15 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 16 Sales of Decongestants by Type: Value 2001-2006
Table 17 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 18 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 19 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 20 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 21 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 22 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 24 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
